Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

GOP Chairwoman: “Happy #PrideMonth!”

Ronna McDaniel, GOP Chairwoman, published a tweet wishing…
Read more

Illinois School Bans 2 Grader for Bringing Bible

A school in Illinois has since decided to reverse their decision…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

NYC Voters Want More Cops

New York City voters are calling for more police, but AOC…
Read more